Cell transplantation for parkinson's disease: Present status

Cellular and Molecular Neurobiology

Volumn 24, Issue 3, 2004, Pages 301-316

  Drucker Colín, René ^a   Verdugo Díaz, Leticia ^b  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Animal models; Chromaffin cells; Grafts; Magnetic fields

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADRENALIN; CALCIUM ION; CATECHOLAMINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; NEUROTOXIN; OXIDOPAMINE;

ADOPTIVE IMMUNOTHERAPY; ADRENAL MEDULLA; AUTOTRANSPLANTATION; BRAIN GRAFT; BRAIN TRANSPLANTATION; CALCIUM TRANSPORT; CELL SURVIVAL; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; CHROMAFFIN CELL; CHRONIC PAIN; CLINICAL RESEARCH; CORPUS STRIATUM; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; EMBRYO CELL; FETUS (ANATOMY); FETUS CELL; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUNTINGTON CHOREA; MESENCEPHALON; MICROSURGERY; NERVOUS TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; STEM CELL; SUBSTANTIA NIGRA; SURGICAL TECHNIQUE; SWINE; TERATOMA; TISSUE GRAFT; TREATMENT OUTCOME; XENOTRANSPLANTATION;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CHROMAFFIN CELLS; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; HUMANS; PARKINSON DISEASE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA; SUS SCROFA;

EID: 3342984956     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CEMN.0000022764.94760.3f     Document Type: Review

References (82)

1. Albin, R. L., Young, A. B., and Penney, J. B. (1989). The functional anatomy of basal ganglia disorders. TINS 12(10):366-374.
2. Allen, G. S., Burns R. S., and Tullipan, M. B. (1989). Adrenal medulary transplantation to the caudate nucleus in Parkinson's disease. Initial clinical results in 18 patients. Arch. Neurol. 46:487-491.
3. Backlund, E.-O., Granberg, P.-O., Hamberger, B., Knutson, E., Martensson, A., Sedvall, G., Seiger, A., and Olson, L. (1985). Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J. Neurosurg. 62:169-173.
4. Barker, R. A. (2002). Repairing the brain in Parkinson's disease: Where next? Mov. Disord. 17(2):233-241.
5. Björklund, L. M., Sánchez-Pernaute, R., Chung, S., Andersson, T., Ching-Chen, I. Y., McNaught, K. P., Brownell, A. L., Jenkins, B. G., Wahlestedt, C., Kim, K. S., and Isacson, O. (2002). Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. PNAS 99(4):2344-2349.
6. Björklund, A., and Steveni, U. (1979). Reconstruction of the nigro-striatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177:555-560.
7. Check, E. (2002). Parkinson's patients show positive response to implants. Nature 416:666.
8. Clarkson, E. D., Zawada, W. M., Adams, F. S., Bell, K. P., and Freed, C. R. (1998). Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats. Brain Res. 806:60-68.
9. Cotzias, G. C., Van Woert, M. H., and Schiffer, L. M. (1967). Aromatic amino acids and modification of Parkinsonism. N. Engl. J. Med. 276:374-379.
10. Crawford, G. D., Jr., Le, W. D., Smith, R. G., Xie, W. J., Stefani, E., and Appel, S. H. (1992). A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J. Neurosci. 12:3392-3398.
11. Date, I., Imaoka, T., Myshohi, Y., Ono, T., Asar, S., and Ohmoto, T. (1996). Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve. Case report. J. Neurosurg. 84(4):685-689.
12. Date, I., and Ohmoto, T. (1996). Neural transplantation and trophic factors in Parkinson's disease: Special reference to chromaffin cell grafting. NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting. Exp. Neurol. 137(2):333-344.
13. Deacon, T., Schumacher, J., Dinsmore, J., Thomas, C., Palmer, P., Kott, S., Edge, A., Penney, D., Kassissieh, S., Dempsey, P., and Isacson, O. (1997). Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat. Med. 3(3):350-353.
14. Del Conte, G. (1907). Einpflanzungen von embryonalem Gewebe ins Gehirn. Beitr. Pathol. Anat. 42:193-201.
15. Drucker-Colín, R., Aguilar-Roblero, R., García- Hernández, F., Fernández Cancino, F., and Bermúdez-Rattoni, F. (1984). Fetal suprachiasmatic nucleus transplants: Diurnal rhythm recovery of lesioned rats. Brain Res. 311:353-357.
16. Drucker-Colín, R., Madrazo, I., Ostrosky-Solís, F., Shkurovich, M., Franco, R., and Torres, C. (1988). Adrenal medullary tissue transplants in the caudate nucleus of Parkinson's patients. Prog. Brain Res. 78:567-574.
17. Drucker-Colín, R., Verdugo-Díaz, L., Méndez, M., Carrillo-Ruiz, J., Morgado-Valle, C., Hernández-Cruz, A., and Corkidi, G. (1994). Comparison between low frequency magnetic (LFM) field stimulation and nerve growth factor (NGF) treatment of cultured chromaffin cells, on neurite growth, noradrenaline release, excitable properties and grafting in nigro-striatal lesioned rats. Mol. Cell. Neurosci. 5:485-498.
18. Drucker-Colín, R., Verdugo-Díaz, L., Morgado-Valle, C., Solís-Maldonado, G., Ondarza, R., Boll, C., Miranda, G., Wang, G. J., and Volkow, N. (1999). Transplant of cultured neuron-like differentiated chromaffin cells in a Parkinson's disease patient: A preliminary report. Arch. Med. Res. 30:33-39.
19. Dunn, E. H. (1917). Primary and secondary findings in a series of attempts to transplant cerebral cortex in the albino rat. J. Comp. Neurol. 27:565-582.
20. Fahn, S. (1986). Parkinson's disease and other basal ganglion disorders. In Asbury, A. K., McKlann, G. M., and McDonald, W. I. (eds.), Clinical Neurobiology, London. Saunders, pp. 1217-1228.
21. Feria-Velasco, A., Castillo-Medina, S., Verdugo-Díaz, L., Castellanos, E., Orozco-Suárez, S., Sánchez-Gómez, C., and Drucker-Colín, R. (1998). Neuronal differentiation of chromaffin cells in vitro, induced by extremely low frequency magnetic fields or nerve growth factor: An histological and ultrastructural comparative study. J. Neurosci. Res. 53:569-582.
22. Fine, A., Hunt, S. P., Oertel, W. H., Nomoto, M., Chuong, P. N., Bond, A., Waters, C., Temlett, J. A., Annett, L., Dunnett, S., Jenner, P., and Marsden, C. D. (1988). Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine. In Gash, D. M., and Sladek, J. R., Jr. (eds.), Transplantation in the Mammalian CNS, Elsevier. Amsterdam, pp. 479-489.
23. Fisher, L. J., and Gage, F. H. (1993). Grafting in the mammalian central nervous system. Physiol. Rev. 73(3):583-616.
24. Flerko, B., and Szentagothai, J. (1957). Oestrogen sensitive neurvous structures in the hypothalamus. Acta Endocrinol (Cpenh). 26(2):121-127.
25. Freed, C. R., Breeze, R. E., and Rosenberg, N. L. (1992). Survival of implanted fetal dopamine cells and neurologic improvement 12-46 months after transplantation for Parkinson's disease. N. Engl J. Med. 327:1549-1555.
26. Freed, C. R., Breeze, R. E., Rosenberg, N. L., Schneck, S. A., Wells, T. H., Barret, J. N., Grafton, S. T., Huang, S. C., Eidelberg, D., and Rottenberg, D. A. (1990). Transplantation of human fetal dopamine cells for Parkinson's disease: Results at 1 year. Arch. Neurol. 47:505-512.
27. Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W. Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. W., Eidelberg, D., and Fahn, S. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344:710-719.
28. Freed, W. J., Morishisa, S. M., Spoo E., Hoffer, B. J., Olson, L., Seiger, A., and Wyatt, R. J. (1981). Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behavior. Nature 292(5821):351-352.
29. Goetz, C. G. (1992). Adrenal medulla. Clin. Restor. Neurol. Neurosci. 4:194.
30. Goetz, C. G., Olanow, C. W., Koller, W. C., Penn, R. D., Cahill, D., Morantz, R., Stebbins, G., Tanner, C. M., Klawans, H. L., Shannon, K. M., Comella, C. L., Witt, T., Cox, C., Wasman, M., and Cauger, L. (1989). Multicenter study of autologous adrenal medullary transplantation of the corpus striatum in patients with advanced Parkinson's disease. N. Engl. J. Med. 320:337-341.
31. Halász, B., Popp, L., Vhlarik, S., and Tima, L. (1965). Further studies on the hormone secretion of the anterior pituitary transplanted into the hypophysiotrophic area of the rat hypothalamus. Endocrinology 77(2):343-355.
32. Hefti, F., Hartikka, J., and Schlumpf, M. (1985). Implantation of PC12 cells into the corpus striatum of rats with lesions of the dopaminergic nigrostriatal neurons. Brain Res. 348:283-288.
33. Hitchcock, E. R., Kenny, B. G., Clough, C. G., Hughes, R. C., Henderson, B. T., and Delta, A. (1990). Stereotactic implantation of fetal neosencephalon. Stereotact. Funct. Neurosurg. 54:282-289.
34. Holden, C. (2002). Versatile cells against intractable diseases. Science 297:500-502.
35. Hurtig, H., Joyce, J., Sladek, J. R., and Trojanowski, J. Q. (1989). Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease. J. Neurol. 25:607-614.
36. Isacson, O. (2002). Models of repair mechanisms for future treatment modalities of Parkinson's disease. Brain Res. Bull. 57(6):839-846.
37. Itakura, T., Uematsu, Y., Nakao, N., Nakai, E., and Nakai, K. (1997). Transplantation of autologous sympathetic ganglion into the brain with Parkinson's disease. Long-term follow-up of 35 cases. Stereotact. Funct. Neurosurg. 69:112-115.
38. Jenner, P. N. (1992). Paroxetine: An overview of dosage, tolerability and safety. Int. Clin Psychopharmacol. 4:69-80.
39. Kelly, P. J., Ahlskog, J. E., Van Heerden, J. A., Carmichael, S. L., Stoddard, S. I., and Bell, G. N. (1989). Adrenal medullary autograft transplantation into the striatum of patients with Parkinson's disease. Mayo Clin. Proc. 64:282-290.
40. Kolarik, J., Nadvornik, P., Dvorak, M., and Andrs, M. (1988). Crossed transvertebral puncture to block spinal ganglion in treatment of pain. Zentralbl. Neurochir. 49:185-188.
41. Kordower, J. H., Cochran, E., Penn, R. D., and Goetz, C. G. (1991). Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann. Neurol. 29:405-412.
42. Koutouzis, T. K., Emerich, D. F., Borlongan, C. V., Freeman, T. B., Cahill, D. W., and Sanberg, P. R. (1994). Cell transplantation for central nervous system disorders. Crit. Rev. Neurobiol. 8:125-162.
43. Langston, J. W., Irwin, I., and Ricaurte, G. A. (1987). Neurotoxins. Parkinsonism and Parkinson's disease. Pharmacol. Ther. 32(1):19-49.
44. Lawrence, M. S., Ho, D. Y., Sun G. H., Steinberg, G. K., and Sapolsky, R. M. (1996). Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J. Neurosci. 16:486-496.
45. Le Gross Clark, W. E. (1940). Neuronal differentiation in implanted foetal cortical tissue. J. Neurol. Psychiatry (Lond.) 3:263-272.
46. Levivier, M., Przedborski, S., Bencsics, C., and Kang, U. J. (1995). Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neuosci. 15:7810-7820.
47. Lindvall, O. (1989). Transplantation into the human brain: Present status and future possibilities. J. Neurol. Neurosurg. Psychiatry (Suppl.): 39-54.
48. Lindvall, O., Backlund, E. O., and Farde, L. (1987). Transplantation in Parkinson's disease: Two cases of adrenal medullary autografts to the putamen. Ann. Neurol. 22:457-468.
49. Lindvall, O., Brundin, P., Widner, H., Rehncrona, S., Gustavii, B., Frackowiak, R., Leenders, K. I., Sawle, G., Rothwell, J. C., Marsden, C. D., and Björklund, A. (1990). Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577.
50. López-Lozano, J. J., Bravo, G. and Abascal, J. (1991). The CPH Neural Transplantation Group grafting of perfused adrenal medullary tissue into the caudate nucleus of patients with Parkinson's disease. J. Neurosurg. 75:234-243.
51. López-Lozano, J. J., Bravo, G., Abascal, J., Brera, B., Santos, H., and Gómez-Angulo, C. (1992). The CPH Neural Transplantation Group. Co-transplantation of peripheral nerve and adrenal medulla in Parkinson's disease. Lancet 339:430.
52. López-Lozano, J. J., Bravo, G., Brera, B., Millan, I., Dargallo, J., Salmean, J., Uria, J., and Insausti, J. (1997). Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-Year follow up in 10 patients. J. Neurosurg. 86(6):931-942.
53. López-Lozano, J. J., Mata, M., and Bravo, G. (2000). Neural transplants in Parkinson disease: Clinical results of 10 years of experience. Group of Neural Transplants of the CPH. Rev. Neurol. 30:1077-1083.
54. Madrazo, I., Drucker-Colín, R., Díaz, V., Martínez-Mata, J., Torres, C., and Becerril, J. J. (1987). Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N. Engl. J. Med. 316:831-834.
55. Madrazo, I., Franco-Bourland, R., and Ostrosky-Solis, F. (1990). Neural transplantation (autoadrenal, fetal nigral and fetal adrenal) in Parkinson's disease: The Mexican experience. Prog. Brain Res. 82:593-602.
56. Mendoza-Ramírez, J. L., Aguilar-Roblero, R., Zainos-Rosales, A., and Drucker-Colín, R. (1991). Fetal substantia nigra and adrenal medullary grafts placed contralateral to the nigrostriatal lesion side induce a decrease in turning behavior but not in dopamine receptor density. Restor. Neurol. Neurosci. 3:277-285.
57. Molina, H., Quinones, A. L., and Ortega, I. (1992). Stereotactic transplantation of foetal ventral mesencephalic cells: Cuban experiences from five patients with idiopathic Parkinson's disease. J. Neural Transplant. Plast. 3:338-339.
58. 2+ channels in neurite growth of cultured chromaffin cells induced by extremely low frequency (ELF) magnetic field stimulation. Cell Tissue Res. 291:217-230.
59. Nikkhah, G. (2001). Neural transplantation therapy for Parkinson's disease: Potential and pitfalls. Brain Res. Bull. 56(6):509.
60. Olanow, C. W., Korkower, J. H., and Freeman, T. B. (1996). Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19(3):102-109.
61. Olson, L., Backlund, E. O., Ebendal, T., Freedman, R., Hamberger, B., Hansson, P., Hoffer, B. J., Lindbloom, U., Myerson, B., Stromberg, I., Sydow, O., and Seiger, A (1991). Intraputamenal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial. Arch. Neurol. 48:373-381.
62. Oyesiku, N. M., and Bakay, R. A. (1993). Central nervous system transplantation. In Crockard, A., Hayward, R., and Hoff, J. T. (eds.), Neurosurgery: The Scientific Basis of Clinical Practice, Blackwell Scientific, London, pp. 448-469.
63. Pallini, R., Fernández, E-., Lauretti, L., Dell' Anna, E., La Marca, F., Gangitano, C., DelFa, A., Olivieri-Sangiacomo, C., Sbriccoli, A., and Rossi, G. F. (1996). Superior cervical ganglion regenerating axons through peripheral nerve grafts and reversal of behavioral deficits in hemiparkinsonian rats. J. Neurosurg. 84(3):487-493.
64. Penn, R. D., Goetz, C. G., Tanner, C. M., Klawans, H. L., Shannn, K. M., Comella, C. L., and Witt, T. R. (1988). The adrenal medullary transplant operation for Parkinson's disease: Clinical observations in five patients. Neurosurgery 22:999-1004.
65. Perlow, M., Freed, W. J., Hoffer, B., Seiger, A., Olson, L., and Wyatt, R. J. (1979). Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204:643-647.
66. Perlow, M. J., Kokoris, G., Gibson, M. J., Silverman, A. J., Kreiger, D. T., and Zimmerman, E. A. (1987). Accessory olfactory bulb transplants correct hypogonadism in mutant mice. Brain Res. 415:158-162.
67. Peterson, D. I., Price M. L., and Small, C. S. (1989). Autopsy findings in a patient who had an adrenal-to-brain transplant for Parkinson's disease. Neurology 39:235-238.
68. Poltorak, M., Isono, M., Freed, W. J., Ronnett G. V., and Snyder, S. H. (1992). Human cortical neuronal cell line (HCN-1): Further in vitro characterization and suitability for brain transplantations. Cell Transplant. 1:3-15.
69. Ranson, S. W. (1909). Transplantation of the spinal ganglion into the brain. Q. Bull. Northwest. Univ. Med. Sch. 11:176-178.
70. Sanberg, P. R., Barlongon, C. V., Othberg, A. L., Saporta. S., Freeman, T. B., and Cameron, D. F. (1997). Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats. Nat. Med. 3(10): 1129-1132.
71. Sanberg, P. R., and Norman, A. B. (1988). Adrenal transplants for Huntington's disease? Nature 335:122.
72. 18F]6-L-fluorodopa studies in two patients with putaminal implants. Ann. Neurol. 31:166-173.
73. Seiger, A., and Olson, L. (1997). Quantification of fiber outgrowth in transplanted central monoamine neurons. Cell Tissue Res. 179:285-316.
74. Shirai, Y. (1921). On the transplantation of rat sarcoma in adult heterogeneous animals. Jpn. Med. World 1:14-15.
75. Sladek, J. R., Jr., and Collier, T. J. (1988). Fetal dopamine neural grafts: Extended reversal of methylphenyltetrahydropine-induced Parkinsonism in monkeys. Prog. Brain Res. 78:497-506.
76. Tello, J. F. (1911). La influencia del neurotropismo en la regeneración de los centros nerviosos. Trab. Lab. Invest. Biol. 9:123-160.
77. Thompson, W. G. (1890). Successsful brain grafting. N.Y. Med. J. 51:701-702.
78. Tresco, P. A., Winn, S. R., Tan, S., Jaeger, C. B., Greene, L. A., and Aebischer, P. (1992). Polymerencapsulated PC12 cells: Long-term survival and associated reduction in lesion-induced rotational behavior. Cell Transplant. 1:255-264.
79. Ungeistedt U., and Arbuthnott, G. W. (1970). Quantitative recording of rotational benavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 18(24):485-493.
80. Verdugo-Díaz, L., Palomero-Rivero, M., and Drucker-Colín, R. (1998). Differentiation of chromaffin cells by extremely low frequency magnetic field changes ratios of catecholamine type messenger. Bioelectrochem. Bioenerg. 46:297-300.
81. Wang, H., and Sagen, J. (1994). Optimization of adrenal medullary allograft conditions for pain alleviation. J. Neural Transplant. Plast. 5:49-64.
82. Zainos-Rosales, A., Aguilar-Roblero, R., Mendoza-Ramírez, J. L., and Drucker-Colín, R. (1993). 2-Deoxyglucose autoradiographic evidence that substantia nigra grafts in 6-hydroxydopamine lesioned animals produce recovery of motor asymmetries by exerting contralateral effects. Neurosci. Lett. 156:99-10.